WHO ICTRP trial
Efficacy and safety of Sacubitril/Valsartan in improving collateral circulation…
ChiCTR2400089459 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400089459 |
|---|---|
| Public title | Efficacy and safety of Sacubitril/Valsartan in improving collateral circulation in hypertensive patients with acute ischemic stroke |
| Scientific title | Efficacy and safety of Sacubitril/Valsartan in improving collateral circulation in hypertensive patients with acute ischemic stroke |
| Primary sponsor | Zhongshan Hospital, Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | acute ischemic stroke with hypertention |
| Interventions | Antihypertension by Sacubitril/Valsartan:Sacubitril/Valsartan, 100-200mg qd;Antihypertension by other agents:Other antihypertensive agents, determined by clinical physicians |
| Registration date | Sep 9, 2024 |
| Target size | Antihypertension by Sacubitril/Valsartan:46;Antihypertension by other agents:46 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: